(Q34498250)

2 August 2017

1 reference

title

Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis (English)

1 reference

2 August 2017

1 reference

Dick T

1

1 reference

2 August 2017

Mierau R

2

1 reference

2 August 2017

Bartz-Bazzanella P

3

1 reference

2 August 2017

Alavi M

4

1 reference

2 August 2017

Stoyanova-Scholz M

5

1 reference

2 August 2017

Kindler J

6

1 reference

2 August 2017

Genth E

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Annals of the Rheumatic Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

61

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

121-127

1 reference

Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Antinuclear antibody in systemic sclerosis (scleroderma).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Eukaryotic expression of recombinant human centromere autoantigen and its use in a novel ELISA for diagnosis of CREST syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Autoantibodies in systemic sclerosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Autoantibodies in the diagnosis of systemicrheumatic diseases

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Scl-86, a marker antigen for diffuse scleroderma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Marker antibodies in scleroderma and polymyositis: clinical associations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Anti-Scl-70 and anti-centromere autoantibodies. Biological markers of 2 forms of systemic scleroderma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Antikinetochore and antitopoisomerase I antibodies in systemic scleroderma: comparative study using immunoblotted recombinant antigens, immunofluorescence, and double immunodiffusion.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Immunological markers of the subsets of systemic scleroderma and its overlap

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Male-type scleroderma: the role of occupational exposure

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Clinical correlation of anticentromere antibodies.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Scl 70 antibody--a specific marker of systemic sclerosis.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1753997

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

27 October 2018

1 reference

12 December 2020

Clinical setting of patients with systemic sclerosis by serum autoantibodies

1 reference

12 December 2020

HLA and clinical associations in systemic sclerosis patients with anti-Th/To antibodies

1 reference

12 December 2020

Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis

1 reference

12 December 2020

HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients

1 reference

12 December 2020

Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay

1 reference

12 December 2020

The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies

1 reference

12 December 2020

Systemic sclerosis: an autoantibody mosaic

1 reference

12 December 2020

Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance

1 reference

12 December 2020

Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases

1 reference

12 December 2020

Antinuclear antibodies in progressive systemic sclerosis

1 reference

12 December 2020

A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis

1 reference

12 December 2020

[Nuclear antibodies as serologic markers in progressive systemic scleroderma]

1 reference

12 December 2020

Clinical subsets of scleroderma: relevance of fluorescent and precipitating antinuclear antibodies

1 reference

12 December 2020

Coexistence of CREST syndrome and primary biliary cirrhosis. Serological studies of two cases

1 reference

12 December 2020

The use of immunoblotting to detect antibodies to nuclear and cytoplasmic antigens. Clinical and serological associations in rheumatic diseases

1 reference

12 December 2020

Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma

1 reference

12 December 2020

Anticentromere antibodies--clinical correlates

1 reference

12 December 2020

Autoantibodies in scleroderma

1 reference

12 December 2020

Silica-induced scleroderma

1 reference

12 December 2020

Are ACA and Scl 70 antibodies mutually exclusive?

1 reference

12 December 2020

Immunogenetic associations of scleroderma-related antinuclear antibodies

1 reference

12 December 2020

[Pulmonary manifestation of progressive systemic scleroderma: prognostic value of centromere antibodies and antibodies to Scl-70 nucleoprotein]

1 reference

12 December 2020

Type III collagen aminopropeptide and laminin P1 levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma

1 reference

12 December 2020

[Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma]

1 reference

12 December 2020

Hydrochloric acid treatment of HEp-2 cells for the detection of masked anticentromere antibody (ACA)

1 reference

12 December 2020

Serological profiles as prognostic clues for progressive systemic scleroderma: the Italian experience

1 reference

12 December 2020

Cutaneous and serologic subsets of systemic sclerosis

1 reference

12 December 2020

A case of rheumatoid arthritis associated with progressive systemic sclerosis and primary biliary cirrhosis in the presence of various autoantibodies

1 reference

12 December 2020

Patients with anticentromere antibodies, clinical features, diagnoses and evolution

1 reference

12 December 2020

A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anti-centromere and anti-SCL-70-antibodies

1 reference

12 December 2020

Autoantibody reactive with RNA polymerase III in systemic sclerosis

1 reference

12 December 2020

A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies

1 reference

12 December 2020

Antihistone antibodies in systemic sclerosis. Association with pulmonary fibrosis

1 reference

12 December 2020

Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma)

1 reference

12 December 2020

Anti-centromere antibodies. Study of 67 positive sera

1 reference

12 December 2020

Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study

1 reference

12 December 2020

Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis

1 reference

12 December 2020

Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis

1 reference

12 December 2020

Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin)

1 reference

12 December 2020

Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus

1 reference

12 December 2020

Anti-topoisomerase II alpha autoantibodies in systemic sclerosis-association with pulmonary hypertension and HLA-B35

1 reference

12 December 2020

Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome

1 reference

12 December 2020

Anticentromere antibody. Clinical Correlations and association with favorable prognosis in patients with scleroderma variants

1 reference

12 December 2020

Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population

1 reference

12 December 2020

Anticentromere antibodies (ACA): clinical distribution and disease specificity

1 reference

12 December 2020

Clinical relevance and HLA association of autoantibodies against the nucleolus organizer region (NOR-90)

1 reference

12 December 2020

High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.61.2.121

1 reference

2 August 2017

1 reference

2 August 2017

1 reference